NCT02553356View on ClinicalTrials.gov

PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy
Interventions
DRUG

PT2385

Trial Locations (1)

Unknown

Spaulding Clinical, West Bend

All Listed Sponsors
lead

Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT02553356 - PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers | Biotech Hunter | Biotech Hunter